Decreased fibrin deposition in hypoxic C3−/− mice. by Eileen M. Bauer (337320)

Decreased peritumoral myofibroblasts in the MC38 S.C. tumors of <i>S100a4-Cre; Ext1</i>^<i>f/f</i> mice. by Ayumi Niwa (6256790)

Kat60 lacking the MIT domain or the MIT domain and linker region detectably colocalizes with only a few, if any, microtubules in cells. by Kyle D. Grode (725568)

FLZ decreased the expression of phospho-APP and APP-CTF. by Xiu-Qi Bao (479278)

2-APB decreased the cytokine secretions in human DC. by Romain Félix (586765)

Silencing of dynamin II decreases apoE secretion. by Maaike Kockx (154125)

DISC1 expression decreases in the course of oligodendrocyte differentiation. by Tsuyoshi Hattori (254566)

Receptor specific silencing decreases NGF induced apoptosis. by Alessandra Micera (294762)

“…A 37.5%-decrease (*) and a 50%-decrease (**) of apoptotic signal were detected respectively in p75^NTR-siRNA and p75^NTR/trkA^NGFR-siRNA (p<.05).…”

Time allocation may not decrease with price for a non-linear microscopic utility of leisure. by Ritwik K. Niyogi (427932)

“…Consequently, <i>TA</i> no longer decreases but may even increase with price (A, lower panel). …”

Effects of siRNA TMPRSS2-ERG on ERG protein expression and cell viability. by Giorgia Urbinati (554921)

“…MTT cell viability assay:</b> VCaP cells were transfected with siRNA TMPRSS2-ERG III (1, 2), TMPRSS2-ERG IV (1) and siRNA Control at 50 nM concentration and incubated for 72h. Bars represent mean ± SD of 2 independent experiments containing 8 replicates for each condition. …”

ATRA improved vimentin organization and decreased its expression. by Carmen Retana (479628)

Growth on stiff substrate results in mild lifespan extension but a decrease in organismal health. by Maria Oorloff (19658113)

VGB decreased activation of the mTOR pathway in vivo. by Bo Zhang (6559)

Low concentrations of siRNA TMPRSS2-ERG III and IV impair TMPRSS2-ERG oncogene and oncoprotein levels but not cell viability. by Giorgia Urbinati (554921)

“…One hundred percent cell viability corresponds to the number of living cells incubated with transfecting agent only. Results are the mean ± SD of two independent experiments containing 8 replicates for each condition. * = <i>p</i><0.05, ** = <i>p</i><0.01, *** = <i>p</i><0.001, significant decrease compared to untreated cells (TA) or to siRNA Control (Kruskal & Wallis followed by Tukey and Dunnet test).…”

LOH resulting in 189R/R produces a strong decrease in drug susceptibility. by Pétra Vande Zande (17628246)

Clinical features of Type 1 Diabetes (T1D) patients. by Adriana Carvalho-Santos (814114)

Subjects:

Juvenile demyelination leads to a substantial decrease in potassium currents in PV interneurons of the PFC. by Sara Hijazi (21656615)

“…Representative traces of TEA-sensitive potassium currents (1mM). <b>D</b>. TEA-sensitive currents were specifically decreased in PV interneurons from mice that received cuprizone treatment compared to control mice (<i>group x voltage two-way repeated measures: n = 10,14 cells from 5 mice per group: F(13,286) = 5.082, p < 0.0001</i>). …”

The fasting glucose (FG) levels are weakly negatively correlated with APRIL serum levels in diabetic patients. by Adriana Carvalho-Santos (814114)

Subjects:

Trehalose decreased PAN-induced apoptosis in human podocytes. by Yu-Lin Kang (663806)

“…<p>Podocyte were treated with PAN (30 µg/ml) or/and Trehalose (50 mM) for 48 h. (<b>A</b>) Trehalose induced autophagy in PAN-treated human podocytes. …”

HFD induces LDs and decreases ER and mitochondria in nephrocytes. by Aleksandra Lubojemska (10746241)

“…<b><a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3001230#pbio.3001230.s007" target="_blank">S2 Data</a></b> provides the source data used for all graphs and statistical analyses. …”